Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, November 27, 2017
Biogen and Alkermes announced they have entered into a global license and collaboration agreement to develop and commercialize ALKS 8700.
read more
Fujifilm will acquire the shares of Biogen’s subsidiary, which holds Biogen’s biologics manufacturing operations in Hillerød, Denmark.
read more
Monday, December 09, 2019
BioDuro has announced the appointment of Kent Payne, Ph.D., as President of its CMC Global Solutions business unit.
read more
Monday, November 29, 2021
BioConnection, an independent CDMO (Contract Development Manufacturing Organization) based in Oss, The Netherlands, specialized in GMP-certified manufacturing of sterile drug products in vials and syringes, today announced that Nykode Therapeutics AS...
read more
Thursday, October 07, 2021
BioCina, a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of microbial-based therapeutics and mRNA vaccines announces the full and final transition from Hospira Adelaide ...
read more
Wednesday, November 29, 2017
BIOCAD and Sothema Labs announced the launch of medicines derived using the technology provided by the Russian manufacturer into the North African market.
read more
Bioasis and Wuxi Biologics announced an initial strategic collaboration for the development and manufacturing of xB3-001, Bioasis’ lead investigational biological candidate to treat brain cancer.
read more
Wednesday, November 17, 2021
BioAgilytix, a global contract research organization (CRO), announced an agreement to be further capitalized by Cinven, a leading international private investment firm focused on building world-class global companies. Cinven will acquire a majority ...
read more
BioAgilytix Labs, LLC (“BioAgilytix”), a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development, announces the appointment, effective immediately, of Euan Menzies as ...
read more
Thursday, November 07, 2019
Bio-Techne announced a commitment to invest between $40 million and $50 million to expand its GMP-grade protein production capacity.
read more
Tuesday, December 12, 2017
Binding Site’s Immunologicals Group has completed a major expansion to their monoclonal antibody product offerings.
read more
Tuesday, February 21, 2012
Service Eliminates Over-Packaging by Providing Deep Knowledge of a
Product’s Stability Barrier Needs Before It Is Packaged . . .
Leading to a “Just Right” Solution for Oral Dose Products in Six Weeks
read more
Wednesday, October 07, 2020
BIAL and Recipharm, have expanded a long-term agreement for the global manufacturing and supply of BIAL’s proprietary molecule opicapone.
read more
Beroni Group, an Australia-based diversified biopharmaceutical enterprise, announced that PENAO Pty Ltd, its majority-owned, Sydney-based anti-cancer drug development company, has signed a drug manufacture contract with Aurigene Pharmaceutical ...
read more
Wednesday, February 09, 2022
Berkshire Sterile Manufacturing (BSM) has added formulation, lyophilization, and method development capabilities to complement their clients’ drug productions.
read more